“Dry January,” the cutting out of alcohol consumption during the first month of the calendar year, entered the public vernacular a little over a decade ago. The idea was first promoted in 2013 by a British charity to encourage alcohol abstinence, or at the very least, healthy moderation. The idea took off as a counterbalance to the excesses of indulgence that often characterize the end-of-year holiday season. As if on cue, the U.S. surgeon general released a report earlier this month linking increased cancer risk to even moderate alcohol use and called for alcohol products to carry a warning label like those found on tobacco products.
Since the early 1990s, the prevailing belief among some in the medical community held that moderate amounts of alcohol may not necessarily be detrimental to overall health and may even have beneficial effects. Despite the surgeon general’s report, the consensus in the benefits versus risks debate remains elusive, a fact summarized well in a recent article in The Atlantic and an accompanying podcast by journalist Derek Thompson. Without wading further into the controversy, it is worth pointing out that there is a rich and growing body of research into the effects of alcohol on human physiology, cognitive and psychological well-being, and longevity, all of which rely on some form of life science metrics to measure these effects.
Physiological signals offer a powerful window into the biological and neurological effects of alcohol consumption, providing objective, real-time insights into the body’s and brain’s response. By measuring electrical, chemical, and physical signals generated by the body, researchers can examine changes in heart rate, brain activity, muscle tone, and more. Commonly used signals in alcohol studies include electroencephalography (EEG) to monitor brain activity, electromyography (EMG) for muscle function, electrocardiography (ECG) for heart rhythms, and electrodermal activity (EDA) and galvanic skin response (GSR) for stress and arousal levels. Each tool captures aspects of how alcohol influences the human system, from cognitive processing impairments to autonomic regulation shifts. In research settings, these signals are applied to explore both short- and long-term effects of alcohol. For example, EEG studies can track alterations in brainwave patterns, shedding light on reduced attention, memory disruption, or impaired decision-making during intoxication. ECG and GSR data, meanwhile, reveal how alcohol modulates cardiovascular activity and stress responses, highlighting its impact on the autonomic nervous system (ANS).
A 2021 study by researchers at Wake Forest University and John Hopkins University School of Medicine used heart rate variability (HRV) to examine the relationship between alcohol abstinence, ANS function, and whole brain functional brain networks among everyday drinkers. Whole brain functional brain networks demonstrate how different parts of the brain work together as a connected system. This study combined functional brain wave mapping generated with resting-state MRI scans during three-day periods of alcohol consumption and abstinence. The effects of abstinence were measured using HRV. Alcohol craving in patients with an alcohol use disorder (AUD) has been associated with high-frequency heart rate variability (HF-HRV) with acute consumption being related to decreasing HF-HRV. During the study, ECG data was collected via a BIOPAC data collection and analysis system. The study concluded that “while brain networks do differ across drinking states in risky drinkers, the change is primarily driven by HRV.”
A current study by a team of German researchers explores the effectiveness of Virtual Reality (VR) in Cue Exposure Therapy (CET), a strategy in Cognitive Behavioral Therapy (CBT) used for treating AUD. Research participants are exposed to VR scenarios with alcohol-related cues. VR with integrated eye tracking offers advantages over real-life scenarios when developing new treatment options, according to the study authors. Participants wore head-mounted displays (HMD) to immerse them in three different scenarios while heart rate, HRV, pupillometry, and EDA were measured. Respiration and ECG data are gathered via a wireless BioNomadix BN-RSPEC while PPG and EDA are gathered with a BN-PPGED. Physiological signal data is then fed to a BIOPAC data acquisition system running AcqKnowledge software for analysis. While the study is ongoing, researchers believe it will lead to a better understanding of the induction of craving in VR cue exposure…” and that it could offer “new diagnostic and therapeutic perspectives…providing a basis for future biofeedback training in VR exposure therapy.”
These are a few of the ways physiological signals are being applied in alcohol-related research. For more information on integrating HRV analysis into your next research study, see our webinar on the topic. Better yet, get hands-on training on a full range of research equipment and techniques at our biannual conference on Tools, Trends, Techniques, and Technologies in Human Physiology, 4T|Phys.
Are you planning an alcohol or addiction-related study? BIOPAC has the tools and our regional sales staff is ready to help you with everything you need.
Recent Comments